Abstinence-contingent incentives improved smoking cessation outcomes among economically disadvantaged smokers with mental illness.
Using data from the TUS-CPS, researchers sought to determine the effect of pharmaceutical smoking cessation aids on long-term quit rates among patients who smoke tobacco.
Contrary to some concerns, persons at high risk for lung cancer who undergo CT lung scans are more likely to attempt smoking cessation regardless of their test results compared with unscreened persons.
ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.
E-cigarettes and replacement nicotine therapy deposit fewer harmful chemicals in the body that smoking.
Annual counseling could reduce prevalence and prevent many smoking-attributable fatalities.
Even patients that quit smoking in their 60s can add years to their lives, researchers find.
An analysis of population trends in England demonstrated that use of electronic cigarettes improves the rate of successful quit attempts, but results in less use of prescription nicotine-replacement therapy products.
When patients ask about safety and using e-cigarettes to stop smoking, doctors give varying advice.
Low aerobic capacity has greater effect on longevity than even high cholesterol, or high blood pressure.
A decreasing number of adolescents are smoking, but e-cigarette use and rates of distracted driving are on the rise for this group.
Swallowing the liquid nicotine appears to affect children under 6 the most, and calls to poison control centers about accidental ingestion have sharply increased.
E-cigarettes have a strong potential to improve population health by reducing or displacing cigarette use. A team of international experts urged the US FDA to have a broad perspective when it comes to regulating e-cigarettes.
Smokers who visit a clinician for lung cancer screening should also be encouraged to quit smoking at that visit. Evidence-based behavioral strategies should be used, at each visit, to motivate smokers to quit.
Patients with cancer, including those with a tobacco-related cancer, do not seem to be more likely to quit smoking than the general population.
Smokers have good reason to quit the habit both before and after a breast cancer diagnosis.
A recent study examined factors that impact patient preferences for web- and phone-based tobacco cessation programs.
Rates of 6-month continuous abstinence after lung cancer screening did not differ between black smokers and white smokers despite a higher likelihood of 24-hour and 7-day quit attempts by black smokers.
This fact sheet explores the harmful effects of tobacco smoke, tobacco addiction, and the immediate and long-term benefits of smoking cessation.
The U.S. Preventive Services Task Force (USPSTF) urges PCPs to offer interventions to help adults, including pregnant women, stop smoking.
Many patients with lung cancer do wish to be offered support to help them quit smoking after surgery, according to a recent study.
Patients that cease smoking shortly before or after a lung cancer diagnosis experience significant survival benefits.
Researchers estimate that 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older in 2011 were attributable to cigarette smoking, according to a newly published study.
Government estimates show smoking reduced in roughly half of U.S. states, but some people may be using alternative tobacco products in addition to cigarettes.
More and better data is needed, U.S. Preventive Services Task Force says, to determine whether electronic cigarettes can help traditional smokers quit the habit.
The NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation can help you plan a successful quit program for your patients who smoke.
Series of focus groups shared their personal experiences with and ideas about smoking cessation.
When participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
Research continues into whether e-cigarettes help smokers quit or actually worsen their habit.
Guanfacine, a medication used to treat hypertension, shows promise as a smoking cessation aid.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|